Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering
Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters. The range of POWERWAND™ products extends Smiths Medical’s vascular access product portfolio and enables greater clinician choice to treat patients.
The POWERWAND™ range of products are clinically differentiated vascular access solutions, supported by nine (9) peer-reviewed papers and nine (9) scientific posters. Bloodstream infections are a known risk associated with vascular access catheters. Conclusions from recent clinical studies show no occurrence of bloodstream infections associated with use of the POWERWAND™ products. Combined, these studies have a total of 35,000 catheter days without bacterial infections.1-3
The POWERWAND™ range of products offers value to healthcare providers looking to offer quality care for their patients. When combined with Smiths Medical’s already strong performing Jelco® IV catheter and Port-A-Cath® products, Smiths Medical now offers clinicians more solutions to treat their patients through a broader portfolio.
“Smiths Medical’s acquisition of Access Scientific enhances our commitment to patient care and outcomes, driving category leadership in our existing vascular access portfolio,” said JehanZeb Noor, Smiths Medical CEO. “We believe this acquisition enhances our position as a trusted medication management solutions company. During this time of uncertainty, we feel privileged to offer our customers on the frontlines more choices for treating their patients.”
About Smiths Medical
A leading supplier of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information, visit www.smiths-medical.com.
About Smiths Group
A global technology company that has been operating for 160 years, delivering products and services for the medical technology, security & defense, general industrial, energy and space & commercial aerospace markets worldwide. Smiths Group employs c. 22,000 colleagues in over 50 countries and is listed on the London Stock Exchange. For more information visit www.smiths.com .
(1) Devries M, Lee J, Hoffman L. Infection free midline catheter implementation at a community hospital (2 years). American Journal of Infection Control. 2019;47(9):1118-1121.
(2) Caparas JV, Hung H-S. Vancomycin Administration Through a Novel Midline Catheter: Summary of a 5-Year, 1086-Patient Experience in an Urban Community Hospital. Journal of the Association for Vascular Access. 2017;22(1):38-41.
(3) Pathak R, Patel A, Enuh H, Adekunle O, Shrisgantharajah V, Diaz K. The Incidence of Central Line–Associated Bacteremia After the Introduction of Midline Catheters in a Ventilator Unit Population. Infectious Diseases in Clinical Practice. 2015;23(3):131-134.
M. Devries was a paid consultant with Access Scientific.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200513005134/en/
Contact information
Smiths Medical Media Relations at media.relations@smiths-medical.com or Ashley Voge at 763-383-3111.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mary Kay Ash Foundation ® Gifts $500,000 Grant to Advance Cancer Research and Early Detection at Baylor Scott & White Health13.11.2025 15:01:00 EET | Press release
The Mary Kay Ash Foundation®, a champion of women’s health innovation for nearly three decades, announced a $500,000 grant to Baylor Scott & White Dallas Foundation to accelerate a pioneering triple-negative breast cancer clinical trial and advance early detection initiatives that shift care from reactive to proactive at the newly established Texas Cancer Interception Institute. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113339900/en/ In recognition of its steadfast, decades-long commitment to women’s health, the Mary Kay Ash Foundation was honored with the prestigious Circle of Care Award at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation. The award celebrates those who have made a profound impact in shaping the future of breast cancer care through advocacy, philanthropy, and innovation. Since its inception, the luncheon has raised more than $42 million to fund research, adva
360Learning Integrates with Workday Learning to Transform Enterprise Learning Experiences13.11.2025 15:00:00 EET | Press release
360Learning, the AI-powered collaborative learning platform that enables organisations to upskill from within, is announcing the integration of its Learning Experience Platform (LXP) into Workday’s Learning platform. Through this integration, 360Learning will enable enterprise organizations to launch AI-powered collaborative learning Academies and help deliver timely upskilling to all learners. Workday Learning customers can now leverage internal subject-matter experts to create impactful training in minutes using 360Learning's AI-powered authoring tools – a process that previously took months. Benjamin Marchal, CEO at 360Learning, said: "This partnership helps support career and company growth, enabling learning teams to build programs that meet today's speed of business. By empowering internal experts with AI-powered authoring tools and collaborative learning capabilities, organizations can preserve and distribute proprietary knowledge to increase the impact of their L&D investment."
Owkin Announces Availability of K Pro in the AWS Marketplace SaaS Category13.11.2025 15:00:00 EET | Press release
Owkin, a leading provider of agentic AI solutions for biopharma, today announced the availability of K Pro in the SaaS category of AWS Marketplace. Customers can now use AWS Marketplace to easily discover, buy, and deploy AI agents solutions, including Owkin’s agentic AI co-pilot for biopharma using their AWS accounts, accelerating agent and agentic workflow development. K Pro helps organizations make smarter decisions across their discovery and development pipeline by delivering decision-grade, data-driven biological insights, enabling customers to increase clinical success rates and change program trajectories. "By offering K Pro in AWS Marketplace we're providing customers with a streamlined way to access our agentic AI co-pilot, helping them buy and deploy agent solutions faster and more efficiently." said Adi Ravia, Head of Product at Owkin. "Our customers in biotech, pharmaceuticals and research are already using these capabilities to access and analyse deep multimodal patient da
ChargePoint Releases Next-Generation Software Platform to Manage Any EV Charging Operation, from Fleets to Employee Parking13.11.2025 15:00:00 EET | Press release
ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, has released a new generation of the ChargePoint Platform, a flexible software solution designed to redefine EV charging. Re-engineered from the ground up, the ChargePoint Platform empowers operators to optimize any charging infrastructure, from a single site to a global network, while ensuring seamless integration with evolving energy systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112330917/en/ ChargePoint has released a new generation of the ChargePoint Platform, a flexible software solution designed to redefine EV charging. “The new ChargePoint Platform is more than just modernized software, it is a catalyst for an electrified future,” said Rick Wilmer, Chief Executive Officer at ChargePoint. “ChargePoint has manifested our deep expertise in EV charging to deliver the industry’s most advanced software platform, which is comp
REPLY: The Board of Directors Approves the Quarterly Financial Report as of 30 September 202513.11.2025 14:23:00 EET | Press release
Today, the Board of Directors of Reply [EXM, STAR: REY] approved the results as at 30 September 2025. The Group's consolidated turnover in the first nine months of the year reached €1,819.8 million, an increase of 9.0% compared to €1,669.6 million recorded on 30 September 2024. The indicators for the period are positive. Consolidated EBITDA was €335.5 million, equal to 18.4% of the consolidated revenues. As of September 2024 EBITDA was €275.5 million. EBIT, from January to September, reached €281.0 million, equal to 15.4% of the consolidated revenues. The corresponding 2024 figure was €224.2 million. Pre-tax profit, from January to September 2025, was €268.1 million, equal to 14.7% of the revenues. As of September 2024 pre-tax profit stood at €216.0 million. For the third quarter of the year, the Group’s performance is positive, with consolidated turnover for the period of €598.5 million compared to €553.8 million of the third quarter 2024. EBITDA, from July to September 2025, was equa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom